Industry experts share insights on how companies are adapting through diversification, regionalization, and resilience-focused supply chain strategies.
MD+DI Senior Editor Amanda Pedersen shares mixed feelings about a nursing program's ostomy unit and her personal experience ...
David Fischel, the St. Louis, MO-based company’s chairman and CEO, is featured in this episode of Let’s Talk Medtech to discuss Stereotaxis’ journey from surviving to thriving. The firm recently ...
Tariffs drive medtech firms to diversify suppliers, boosting resilience but raising costs by 20-40%. Domestic sourcing gains ...
Deborah Appleyard, of Johnson & Johnson MedTech, explores how integrating the patient perspective into every stage of the ...
Cut 75% of your prototyping costs and deliver medical devices in days, not weeks—discover how leading OEMs do it.
Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors ...
In late 2000, the medtech industry directed its ire toward the Health Care Financing Administration (HCFA), which we now know ...
It was a tough year in some aspects for the medtech. But here are five reasons the industry has to be thankful.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback